Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3978/j.issn.2306-9759.2015.03.01 http://scihub22266oqcxt.onion/10.3978/j.issn.2306-9759.2015.03.01 C4923660!4923660!27358874     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stem+Cell+Investig 2015 ; 2 (ä): ä Nephropedia Template TP {{tp|p=27358874|t=2015. Mesenchymal stem cells as delivery vectors for anti-tumor therapy |pdf=|usr=}}{{27358874}} gab.com Text Mesenchymal stem cells as delivery vectors for anti-tumor therapy JO: Stem Cell Investig http://www.kidney.de/pget.php?&tw=1&pmid=27358874 #FOAvip Recent studies have demonstrated mesenchymal stem cells (MSCs) are able to migrate specifically to tumors and their metastatic sites when administered intravenously. This characteristic tumor tropism has opened up an emerging field to utilize MSCs as vectors to deliver anti-cancer agents for targeted therapies. Genetically engineered MSCs can specifically migrate to various tumors and locally secrete therapeutic proteins, such as interferon ? (IFN-?) and IFN-?, interleukin 12 and 24, tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or suicide gene/enzyme prodrug. In addition, MSCs have also been engineered to deliver oncolytic viruses and drug-loaded nanoparticles. Here, we present the characteristics of MSCs, the current progress on MSC mediated anti-cancer agents delivery systems and the interaction between MSCs and tumors. Twit Text FOAVip Mesenchymal stem cells as delivery vectors for anti-tumor therapy ????Stem Cell Investig http://www.kidney.de/pget.php?&tw=1&pmid=27358874 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27358874 #FOAvip English Wikipedia <ref>{{Cite pmid|27358874}}</ref> Mesenchymal stem cells as delivery vectors for anti-tumor therapy #MMPMID27358874 Li Z; Fan D; Xiong D Stem Cell Investig 2015[]; 2 (ä): ä PMID27358874show ga Recent studies have demonstrated mesenchymal stem cells (MSCs) are able to migrate specifically to tumors and their metastatic sites when administered intravenously. This characteristic tumor tropism has opened up an emerging field to utilize MSCs as vectors to deliver anti-cancer agents for targeted therapies. Genetically engineered MSCs can specifically migrate to various tumors and locally secrete therapeutic proteins, such as interferon ? (IFN-?) and IFN-?, interleukin 12 and 24, tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or suicide gene/enzyme prodrug. In addition, MSCs have also been engineered to deliver oncolytic viruses and drug-loaded nanoparticles. Here, we present the characteristics of MSCs, the current progress on MSC mediated anti-cancer agents delivery systems and the interaction between MSCs and tumors. äMesenchymal stem cells as delivery vectors for anti-tumor therapy (epmc).pdf DeepDyve Pubget Overpricing